Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study

[1] Lim SS(2012)A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2224-2260

[2] Vos T(2016)Untreated, Uncontrolled, and Apparent Resistant Hypertension: Results of the German Health Examination Survey 2008–2011 J Clin Hypertens (Greenwich) 18 1146-1154

[3] Flaxman AD(2021)Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches Int J Mol Sci 22 3850-47

[4] Danaei G(2014)Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment Lancet Diabetes Endocrinol 2 634-51

[5] Shibuya K(2019)Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys Lancet. 394 639-916

[6] Adair-Rohani H(1998)Does hypertension confer a hypercoagulable state? J Hypertens 16 913-278

[7] Sarganas G(1990)Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease J Intern Med 227 273-186

[8] Neuhauser HK(1993)Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients Scand J Clin Lab Invest 53 179-24

[9] Medina-Leyte DJ(1994)Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study J Clin Epidemiol 47 513-472

[10] Zepeda-Garcia O(1992)Rheological determinants of blood pressure in a Scottish adult population J Hypertens 10 467-297

[1] Lim SS(2012)A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2224-2260

[2] Vos T(2016)Untreated, Uncontrolled, and Apparent Resistant Hypertension: Results of the German Health Examination Survey 2008–2011 J Clin Hypertens (Greenwich) 18 1146-1154

[3] Flaxman AD(2021)Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches Int J Mol Sci 22 3850-47

[4] Danaei G(2014)Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment Lancet Diabetes Endocrinol 2 634-51

[5] Shibuya K(2019)Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys Lancet. 394 639-916

[6] Adair-Rohani H(1998)Does hypertension confer a hypercoagulable state? J Hypertens 16 913-278

[7] Sarganas G(1990)Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease J Intern Med 227 273-186

[8] Neuhauser HK(1993)Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients Scand J Clin Lab Invest 53 179-24

[9] Medina-Leyte DJ(1994)Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure. The Northern Sweden MONICA Study J Clin Epidemiol 47 513-472

[10] Zepeda-Garcia O(1992)Rheological determinants of blood pressure in a Scottish adult population J Hypertens 10 467-297